Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Detection of donor-derived CMV-specific T cells in cerebrospinal fluid in a case of CMV meningoencephalitis after cord blood stem cell transplantation.

Ikegame K, Kato R, Fujioka T, Okada M, Kaida K, Ishii S, Yoshihara S, Inoue T, Taniguchi K, Tamaki H, Soma T, Ogawa H.

Int J Hematol. 2013 Feb;97(2):287-90. doi: 10.1007/s12185-012-1231-6. Epub 2012 Dec 29.

PMID:
23271411
2.

Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.

McGoldrick SM, Bleakley ME, Guerrero A, Turtle CJ, Yamamoto TN, Pereira SE, Delaney CS, Riddell SR.

Blood. 2013 Apr 4;121(14):2796-803. doi: 10.1182/blood-2012-09-453720. Epub 2013 Feb 14.

3.

Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients.

Zhou W, Longmate J, Lacey SF, Palmer JM, Gallez-Hawkins G, Thao L, Spielberger R, Nakamura R, Forman SJ, Zaia JA, Diamond DJ.

Blood. 2009 Jun 18;113(25):6465-76. doi: 10.1182/blood-2009-02-203307. Epub 2009 Apr 15.

4.
5.

Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report.

Kang GW, Hong HL, Lee IH, Ahn KS, Kim JD, Choi DL.

Transplant Proc. 2016 May;48(4):1208-11. doi: 10.1016/j.transproceed.2016.01.021.

PMID:
27320588
6.

Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.

Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T.

Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.

7.
8.

[Changes in peripheral lymphocyte subfraction in cytomegalovirus infections during the early stage of allogenic peripheral blood stem cell transplantation].

Li TS, Qin HY, Chen H, Jiang M, Wang HL, Wang AX.

Zhonghua Nei Ke Za Zhi. 2003 Jun;42(6):396-9. Chinese.

PMID:
12895323
9.

Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells.

Komatsu H, Kogawa K, Nonoyama S, Inui A, Sogo T, Fujisawa T, Klenerman P.

J Med Virol. 2006 Dec;78(12):1616-23.

PMID:
17063516
10.
11.

Reconstitution of HLA-A*2402-restricted cytomegalovirus-specific T-cells following stem cell transplantation.

Gondo H, Himeji D, Kamezaki K, Numata A, Tanimoto T, Takase K, Aoki K, Henzan H, Nagafuji K, Miyamoto T, Ishikawa F, Shimoda K, Inaba S, Tsukamoto H, Horiuchi T, Nakashima H, Otsuka T, Kato K, Kuroiwa M, Higuchi M, Shibuya T, Kamimura T, Kuzushima K, Tsurumi T, Kanda Y, Harada M.

Int J Hematol. 2004 Dec;80(5):441-8.

PMID:
15646657
12.

Detection of β-herpesviruses in Polish adult cord blood stem cell recipients by real-time PCR: single centre study.

Dzieciątkowski T, Przybylski M, Basak GW, Torosian T, Tomaszewska A, Jędrzejczak WW, Młynarczyk G.

Arch Immunol Ther Exp (Warsz). 2010 Dec;58(6):467-72. doi: 10.1007/s00005-010-0096-8. Epub 2010 Sep 25.

PMID:
20872080
13.

Timing of CMV-specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation.

Espigado I, de la Cruz-Vicente F, BenMarzouk-Hidalgo OJ, Gracia-Ahufinger I, Garcia-Lozano JR, Aguilar-Guisado M, Cisneros JM, Urbano-Ispizua A, Perez-Romero P.

Transpl Int. 2014 Dec;27(12):1253-62. doi: 10.1111/tri.12406. Epub 2014 Oct 21.

14.

[Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].

Kılınçkaya Doğan H, Mutlu E, Köksoy S, Yılmaz VT, Koçak H, Çolak D, Mutlu D, Günseren F, Dinçkan A, Aliosmanoğlu İ, Süleymanlar G, Gültekin M.

Mikrobiyol Bul. 2016 Apr;50(2):224-35. Turkish.

15.

Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation.

Ogonek J, Verma K, Schultze-Florey C, Varanasi P, Luther S, Schweier P, Kühnau W, Göhring G, Dammann E, Stadler M, Ganser A, Koehl U, Koenecke C, Weissinger EM, Hambach L.

J Immunol. 2017 Jul 15;199(2):792-805. doi: 10.4049/jimmunol.1601992. Epub 2017 Jun 19.

PMID:
28630092
16.

Manufacturing of highly functional and specific T cells for adoptive immunotherapy against virus from granulocyte colony-stimulating factor-mobilized donors.

Beloki L, Ramírez N, Olavarría E, Samuel ER, Lowdell MW.

Cytotherapy. 2014 Oct;16(10):1390-408. doi: 10.1016/j.jcyt.2014.05.009. Epub 2014 Jun 18.

PMID:
24954783
17.

Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.

Giménez E, Muñoz-Cobo B, Solano C, Amat P, de la Cámara R, Nieto J, López J, Remigia MJ, Garcia-Noblejas A, Navarro D.

Transpl Infect Dis. 2015 Jun;17(3):361-70. doi: 10.1111/tid.12391. Epub 2015 Jun 1.

PMID:
25850900
18.

Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.

Lemmermann NA, Reddehase MJ.

Med Microbiol Immunol. 2016 Dec;205(6):549-561. Epub 2016 Aug 18. Review.

PMID:
27539576
19.

Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants.

Reusser P, Attenhofer R, Hebart H, Helg C, Chapuis B, Einsele H.

Blood. 1997 May 15;89(10):3873-9.

20.

Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.

Tischer S, Dieks D, Sukdolak C, Bunse C, Figueiredo C, Immenschuh S, Borchers S, Stripecke R, Maecker-Kolhoff B, Blasczyk R, Eiz-Vesper B.

J Immunol Methods. 2014 Jun;408:101-13. doi: 10.1016/j.jim.2014.05.011. Epub 2014 May 28.

PMID:
24877879

Supplemental Content

Support Center